Stevanato Group
STVN • NYSE
Stevanato Group is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Franco Stevanato, with a market cap of $3.7B.
CEOFranco Stevanato
Next Earnings
Upcoming earnings announcement for Stevanato Group
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.12
Revenue Estimate
$310.8M
Earnings History
Past 12 earnings reports for Stevanato Group
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | $0.21Est: $0.20 | +5.0% | $403.4MEst: $384.3M | +5.0% | — |
| Nov 6, 2025 | Q3 2025 | $0.16Est: $0.14 | +14.3% | $354.5MEst: $335.8M | +5.6% | — |
| Aug 5, 2025 | Q2 2025 | $0.13Est: $0.11 | +18.2% | $317.5MEst: $302.8M | +4.8% | — |
| May 8, 2025 | Q1 2025 | $0.11Est: $0.11 | 0.0% | $269.8M | — | — |
| Mar 6, 2025 | Q4 2024 | $0.20Est: $0.19 | +5.3% | $352.8MEst: $322.1M | +9.5% | — |
| Nov 5, 2024 | Q3 2024 | $0.13Est: $0.14 | -7.1% | $305.4MEst: $298.3M | +2.4% | — |
| Aug 6, 2024 | Q2 2024 | $0.10Est: $0.11 | -9.1% | $279.5MEst: $278.7M | +0.3% | — |
| May 9, 2024 | Q1 2024 | $0.09Est: $0.12 | -25.0% | $256.3MEst: $254.1M | +0.9% | — |
| Mar 7, 2024 | Q4 2023 | $0.19Est: $0.21 | -7.6% | $345.1MEst: $354.3M | -2.6% | — |
| Oct 31, 2023 | Q3 2023 | $0.16Est: $0.16 | 0.0% | $295.4MEst: $297.3M | -0.6% | — |
| Jul 28, 2023 | Q2 2023 | $0.15Est: $0.14 | +7.1% | $278.3MEst: $276.9M | +0.5% | — |
| May 4, 2023 | Q1 2023 | $0.12Est: $0.13 | -7.7% | $255.4MEst: $260.4M | -1.9% | — |